Seaport Res Ptn Brokers Raise Earnings Estimates for Itron

Itron, Inc. (NASDAQ:ITRI - Free Report) - Investment analysts at Seaport Res Ptn raised their Q2 2025 earnings per share (EPS) estimates for shares of Itron in a report issued on Friday, May 2nd. Seaport Res Ptn analyst S. Graham now expects that the scientific and technical instruments company will post earnings of $1.35 per share for the quarter, up from their prior forecast of $1.23. The consensus estimate for Itron's current full-year earnings is $5.33 per share. Seaport Res Ptn also issued estimates for Itron's FY2025 earnings at $5.64 EPS, Q1 2026 earnings at $1.45 EPS and Q2 2026 earnings at $1.45 EPS.

ITRI has been the topic of a number of other reports. Canaccord Genuity Group increased their target price on Itron from $130.00 to $132.00 and gave the stock a "buy" rating in a report on Wednesday, February 26th. Guggenheim reaffirmed a "buy" rating and issued a $133.00 price objective on shares of Itron in a research note on Thursday, April 17th. StockNews.com cut shares of Itron from a "strong-buy" rating to a "buy" rating in a report on Saturday, March 1st. Oppenheimer upped their target price on shares of Itron from $124.00 to $131.00 and gave the stock an "outperform" rating in a report on Wednesday, February 26th. Finally, Piper Sandler boosted their price objective on Itron from $119.00 to $124.00 and gave the stock a "neutral" rating in a report on Thursday, February 27th. Three investment analysts have rated the stock with a hold rating and nine have assigned a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and a consensus target price of $127.64.

Itron Price Performance

ITRI stock opened at $108.23 on Monday. The stock has a market capitalization of $4.93 billion, a PE ratio of 22.18, a price-to-earnings-growth ratio of 0.81 and a beta of 1.31. The company's 50-day moving average is $104.37 and its 200-day moving average is $107.48. The company has a debt-to-equity ratio of 0.91, a current ratio of 3.36 and a quick ratio of 2.83. Itron has a 1 year low of $90.11 and a 1 year high of $124.90.

Itron (NASDAQ:ITRI - Get Free Report) last issued its quarterly earnings results on Thursday, May 1st. The scientific and technical instruments company reported $1.52 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.30 by $0.22. The firm had revenue of $607.15 million for the quarter, compared to analyst estimates of $608.86 million. Itron had a return on equity of 19.03% and a net margin of 9.37%. The company's revenue was up .6% compared to the same quarter last year. During the same period in the previous year, the firm earned $1.24 earnings per share.

Insider Buying and Selling at Itron

In related news, CFO Joan S. Hooper sold 2,322 shares of the firm's stock in a transaction that occurred on Monday, February 24th. The shares were sold at an average price of $92.90, for a total value of $215,713.80. Following the completion of the transaction, the chief financial officer now directly owns 92,076 shares of the company's stock, valued at approximately $8,553,860.40. This trade represents a 2.46 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, CAO David Marshall Wright sold 317 shares of the business's stock in a transaction on Monday, February 24th. The shares were sold at an average price of $92.90, for a total transaction of $29,449.30. Following the sale, the chief accounting officer now directly owns 8,108 shares in the company, valued at $753,233.20. The trade was a 3.76 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 4,037 shares of company stock valued at $385,815. Company insiders own 1.45% of the company's stock.

Institutional Inflows and Outflows

Several large investors have recently added to or reduced their stakes in the stock. Franklin Resources Inc. lifted its holdings in shares of Itron by 611.9% in the third quarter. Franklin Resources Inc. now owns 282,828 shares of the scientific and technical instruments company's stock worth $31,128,000 after buying an additional 243,102 shares in the last quarter. Principal Financial Group Inc. lifted its stake in Itron by 4.5% in the 3rd quarter. Principal Financial Group Inc. now owns 248,077 shares of the scientific and technical instruments company's stock worth $26,497,000 after purchasing an additional 10,677 shares in the last quarter. GAMMA Investing LLC grew its position in shares of Itron by 15.6% during the 4th quarter. GAMMA Investing LLC now owns 1,177 shares of the scientific and technical instruments company's stock valued at $128,000 after purchasing an additional 159 shares in the last quarter. Oliver Luxxe Assets LLC raised its position in shares of Itron by 4.2% in the fourth quarter. Oliver Luxxe Assets LLC now owns 23,422 shares of the scientific and technical instruments company's stock worth $2,543,000 after buying an additional 934 shares in the last quarter. Finally, Green Alpha Advisors LLC boosted its stake in Itron by 7.2% during the fourth quarter. Green Alpha Advisors LLC now owns 5,878 shares of the scientific and technical instruments company's stock valued at $638,000 after buying an additional 395 shares during the period. Institutional investors own 96.19% of the company's stock.

About Itron

Itron, Inc, a technology, solutions, and service company, provides end-to-end solutions that help manage energy, water, and smart city operations worldwide. It operates in three segments: Device Solutions, Networked Solutions, and Outcomes. The Device Solutions segment offers hardware products that are used for measurement, control, or sensing, such as standard gas, electricity, water, and communicating meters, as well as heat and allocation products.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.